Ralph
DeFronzo, MD
- Endocrinology
- Nephrology
If you're an existing patient of Dr. DeFronzo, please connect via MyChart
Locations
-
-
Diabetes, Obesity and Metabolic Health - UT Health Gateway
8435 Wurzbach Rd
San Antonio, TX 78229 -
210-450-9800
-
210-450-2103
-
About Me
Gender
Male
Languages
English
Credentials
Education
Medical School:
Spaulding/Harvard Medical School
Residency:
Johns Hopkins University School of Medicine
Fellowship:
National Institute of Health
Qualifications
Board Certification:
American Board of Internal Medicine/Nephrology
Treatment and Care
Specific areas of interest and expertise include:
- Adrenal disorders
- Calcium disorders
- Cholesterol and lipid disorders
- Diabetes management
- Hormone imbalance
- Hypoglycemia
- Menopause and hormonal transition
- Metabolic Syndrome
- Obesity
- Osteoporosis and bone health
- Pituitary disorders
- Polycystic Ovary Syndrome
- Reproductive hormone disorders
- Thyroid disorders
- Vitamin D Deficiency
External Links
-
Diabetes Cured without Side Effects
-
Cure for diabetes: Breakthrough could end insulin shots for good
-
Texas scientists closer to diabetes cure with unconventional approach
-
Virus carrying and gene transfers could be used to reverse type 1 diabetes
-
San Antonio scientists trick the body into curing diabetes in mice
-
Effectiveness of A GLP-1 Receptor Agonist Plus A TZD for Type 2 Diabetes
-
San Antonio researcher receives top American diabetes award
-
University cancer, diabetes experts to speak at 29th Annual Update in Medicine Conference
-
U.S. Surgeon General Carmona calls obesity ‘the terror within’
-
Preeminent diabetes researcher DeFronzo honored with UT Health Science Center’s highest award
-
Type 2 diabetes studies seek participants
-
Study comparing type 2 diabetes medications seeks volunteers
-
Starting on 3 drugs at time of diagnosis benefits type 2 diabetics
-
Scientists find previously unseen effects of protein buildup in the diabetic baboon pancreas
-
San Antonio partnership makes Top 50 Hospitals in 3 specialties
-
Researchers collaborate to examine mystery illness that plagues women
-
Health Science Center researchers attract record $189 million
-
Drug prevents type 2 diabetes in majority of high- risk individuals
-
Drug lowers conversion to type 2 diabetes by 81% in multicenter research study
-
Diabetes, chest pain among issues studied by Kleberg Scholars
-
4 in School of Medicine honored by American College of Physicians